Loading ...

Blob

Smart Reasoning:

C&E

See more*

Qaagi - Book of Why

Causes

Effects

important factorsinfluencingpoor adherence

Major factorsinfluencingpoor adherence

Antirejection drugs significantly reduce patient 's quality of lifeoften causingpoor adherence to the treatment.6

4.6%).9 Of 36 subjects who experienced virologic failure , development of drug resistance and/orwere contributingpoor adherence

the number of co - morbidities(passive) influenced bypoor adherence

4.6%).4,6 Of 36 subjects who experienced virologic failure , development of drug resistance and/orwere contributingpoor adherence

some adverse events ( cough , rhinitis , hyperkalemia , acute kidney injury and angioedema ) related to ACEIs or ARBsmight causepoor adherence

cognitive dysfunctionmay ... causepoor adherence

2During clinical drug trialscould leadpoor adherence

numerous practical challengesmay causepoor adherence

it so complexto causepoor adherence

Underfiring an overglaze will prevent the glaze from becoming soft enough to receive the colourthus causingpoor adherence

12 ] butcan ... causepoor adherence

barrierscausingpoor adherence

their mind ... novel features or designsmight causepoor adherence

orderto preventpoor adherence

lack of response to medication BOSTONmay causelack of response to medication BOSTON

Foot ulcer recurrence(passive) caused byFoot ulcer recurrence

from application on site with lack of cleanlinessresultingfrom application on site with lack of cleanliness

to more complications and higher hospitalization ratesleadsto more complications and higher hospitalization rates

hospitalization and increases the economic burden of diabetic patientleadshospitalization and increases the economic burden of diabetic patient

30 % to 50 % of treatment failures and 125,000 deaths per year in the US among patients diagnosed with a chronic diseasecauses30 % to 50 % of treatment failures and 125,000 deaths per year in the US among patients diagnosed with a chronic disease

to drug - resistant strains of HIV , which are not only associated with increased mortality in patients [ 12 , 13 ] but also can be transmitted to others [ 14 , 15also contributesto drug - resistant strains of HIV , which are not only associated with increased mortality in patients [ 12 , 13 ] but also can be transmitted to others [ 14 , 15

in lowered vaccine efficacymay resultin lowered vaccine efficacy

to failure of HIV drug trials ( 3/4 ) FasterCuresleadsto failure of HIV drug trials ( 3/4 ) FasterCures

to treatment failure , viral resistance , and related infectionsinvariably leadsto treatment failure , viral resistance , and related infections

to antibiotic resistant strainshas leadto antibiotic resistant strains

drug resistance to developcan causedrug resistance to develop

in failure to prevent viral replication as well as an increased risk of developing drug resistancewould resultin failure to prevent viral replication as well as an increased risk of developing drug resistance

usuallyleadsusually

to HIV drug resistanceleadsto HIV drug resistance

to drug resistance and drug failurecould leadto drug resistance and drug failure

to less than optimal treatment outcomes , which in turn leads to increases in illness , hospital admissions , mortality , and overall healthcare costsleadsto less than optimal treatment outcomes , which in turn leads to increases in illness , hospital admissions , mortality , and overall healthcare costs

in the development of drug resistance and poor virologic outcomesmay resultin the development of drug resistance and poor virologic outcomes

to a situation where your tablets are no longer managing your HIV effectivelymay leadto a situation where your tablets are no longer managing your HIV effectively

huge financial lossescauseshuge financial losses

to problems with resistance to the medicationleadsto problems with resistance to the medication

this form of drug resistance(passive) is ... caused bythis form of drug resistance

to inadequate glycaemic control , which in turn increases the risk of diabetic complications and mortality.7leadsto inadequate glycaemic control , which in turn increases the risk of diabetic complications and mortality.7

from issues surrounding cosmetic acceptability , which leads to loss of effect and patient dissatisfaction with the treatmentcan resultfrom issues surrounding cosmetic acceptability , which leads to loss of effect and patient dissatisfaction with the treatment

in treatment failure , resistance to treatment , and increased mortalityresultedin treatment failure , resistance to treatment , and increased mortality

to reduced rates of responseleadsto reduced rates of response

to the virologic failure of patients using cheaper first - line treatment regimens and the spread of drug resistant forms of the viruscan leadto the virologic failure of patients using cheaper first - line treatment regimens and the spread of drug resistant forms of the virus

to the emergence of drug resistant strains of the virus and transmission during risky behaviorscan contributeto the emergence of drug resistant strains of the virus and transmission during risky behaviors

to reduced clinical benefit , a raised incidence of secondary complicationsleadsto reduced clinical benefit , a raised incidence of secondary complications

in peeling or flakingresultingin peeling or flaking

to unsuppressed virus , more advanced HIV disease and poorer health outcomescan leadto unsuppressed virus , more advanced HIV disease and poorer health outcomes

treatment failure , complications and the development of drug resistanceresultingtreatment failure , complications and the development of drug resistance

in worsening of the condition , death , and increases in the cost of health carecan resultin worsening of the condition , death , and increases in the cost of health care

in unnecessary disease progression , treatment complications , reduced functional abilities , lower quality of life , and premature death.39can resultin unnecessary disease progression , treatment complications , reduced functional abilities , lower quality of life , and premature death.39

to ongoing replication of HIV and subsequent loss of CD4 lymphocytescan also leadto ongoing replication of HIV and subsequent loss of CD4 lymphocytes

in poor outcomeswill often resultin poor outcomes

in poor productalmost invariably resultsin poor product

to treatment - limiting drug resistancecan leadto treatment - limiting drug resistance

to worsening of diseaseleadsto worsening of disease

to ] troublesome symptoms , time off work and treatment in hospitalcan leadto ] troublesome symptoms , time off work and treatment in hospital

Blob

Smart Reasoning:

C&E

See more*